Log In
BCIQ
Print this Print this
 

tetravalent dengue vaccine (CYD-TDV, Dengvaxia)

Also known as: ChimeriVax (ChimeriVax-Dengue)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionChimeric tetravalent dengue vaccine consisting of live attenuated yellow fever virus 17D strain with structural genes replaced with the corresponding dengue structural genes
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentMarketed
Standard IndicationDengue fever
Indication DetailsPrevent dengue fever
Regulatory Designation U.S. - Fast Track (Prevent dengue fever)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/08/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today